Mpox outbreak study in Equateur Province, DRC
Part of Infections clinical trials.
This study looks at the mpox outbreak in Equateur Province, Democratic Republic of Congo. It aims to understand who gets sick and how the virus spreads, which may help with future prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were born before 1984 (or up to 1984 to allow for date mistakes in remote areas).
- You have skin sores or rashes that a doctor thinks could be mpox.
- You or a family member can give permission for you to be in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at people with mpox in the DR Congo to learn more about the outbreak. If you have a rash that fits the mpox pattern and a positive lab test, you may be able to join.
This study tests whether a single dose of the LC16m8 mpox vaccine is safe and works in people living in the Democratic Republic of Congo. It also monitors for side effects and tracks mpox cases to see how well the vaccine protects the community.
This study follows people with mpox and their close contacts in Guinea to learn how the virus spreads and to measure how well the mpox vaccine works. You would be involved for up to two months and help improve prevention and care.
This study looks at how mpox affects people, how it spreads, and what happens over time. If you are being tested for mpox, you may join to help researchers learn more.
This study looks at how well your immune system remembers the mpox virus after you've been infected. It may help researchers understand protection against future infections.
This study is testing a new way to diagnose mpox (formerly monkeypox) using a sample from your skin sores. If you have symptoms that look like mpox, this test might help confirm the diagnosis quickly.
Hear when a new Mpox (Monkeypox) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.